NCT04670289View on ClinicalTrials.gov

Safety, Tolerability, and Pharmacokinetics of Single Dose TenoMiR as a Treatment for Tennis Elbow

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 14, 2020

Primary Completion Date

May 19, 2021

Study Completion Date

August 18, 2021

Conditions
Tennis Elbow
Interventions
DRUG

TenoMiR (Low Dose)

Mimic of miR29a

DRUG

TenoMiR (Medium Dose)

Mimic of miR29a

DRUG

TenoMiR (High Dose)

Mimic of miR29a

DRUG

Placebo

0.9% saline

Trial Locations (1)

Unknown

MAC Clinical Research, Manchester

Sponsors
All Listed Sponsors
lead

Causeway Therapeutics

INDUSTRY